Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

INVICRO

Home Clinical Trial Sponsors and OrganizationsINVICRO

INVICRO

2023 120TH Ave NE, Bellevue, Washington, United States

Also known as:

imanova limited

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

14

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

10

71.4%

Early Phase 1

4

28.6%

Trial Status Distribution

Completed

13

92.9%

Terminated

1

7.1%

Clinical Trials

Trials sponsored by this organization (14)

Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease

Dec 202516 participants

First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain

Nov 202511 participants

Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein

Jan 20225 participants

Plasma P-tau2017 and Quantitative Amyloid PET Imaging

Aug 2021140 participants

Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444

Jun 20213 participants

Evaluation of [18F]APN-1607 as a PET Biomarker

May 202112 participants

Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain

Dec 202012 participants

Assessment of the Biodistribution and Safety of [18F]MNI-1054

Oct 20184 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials14
Approvals
News

Back to Organizations